Dominion Aesthetic Technologies Closes $23.7 Million Series B Financing to Accelerate the Commercialization of EON

January 29, 2021
Dominion Aesthetic Technologies Closes 237 Million Series B Financing to Accelerate the Commercialization of EON image

EON is an FDA-cleared 1064 nm robotic laser device used for touchless, external non-invasive lipolysis of the abdomen.

Dominion Aesthetic Technologies, developers of EON, closed Series B financing, raising a total of $23.7 million. 

The series B funding will accelerate the manufacturing and commercialization of EON, an FDA-cleared 1064 nm robotic laser device used for touchless, external non-invasive lipolysis of the abdomen.

"We appreciate the confidence our investors have shown in the company with our Series B round closing oversubscribed, which will allow us to focus on the manufacturing and commercialization of EON at an exciting and pivotal time in the company's development," says Dominion Aesthetic Technologies' Chief Financial Officer, Gerry Sheridan, in a news release.

The company also relocated from San Antonio to its Houston headquarters this month. The new corporate office, located within 5 minutes of the Houston Bush Intercontinental Airport, is in a Qualified Opportunity Zone. The new EON Demonstration Training Center will facilitate practitioners' opportunities to experience EON first-hand and develop their practical expertise as Dominion Aesthetic Technologies launches the device throughout 2021.

"There are very few opportunities to grow a company this rapidly, and this is clearly due to our innovative product and solid network base. None of this would be possible without our world-class investors and our experienced commercialization team," says CEO of Dominion Aesthetic Technologies Cooper Collins.

More on EON

As no part of EON directly touches the patient, it is unique in its class. There are no disposables or treatment applicators as seen in other body contouring devices. EON's treatment head combines a laser, which heats adipose tissue to induce apoptosis, with a jet-inspired impingement cooling system that protects the skin and provides patient comfort. The microprocessor-controlled articulated robotic arm delivers consistent applications of laser energy over the designated treatment area. EON delivers superior fat reduction results of the full abdomen in 60 minutes without the need for post-procedure massages.

Practitioners who wish to join EON's growing priority waitlist can schedule a virtual or live demonstration at www.eonlaser.com or contact the team at info@dominionaesthetic.com.

Facebook Comments

Register

We’re glad to see you’re enjoying PracticalDermatology…
but how about a more personalized experience?

Register for free